
Cardioonc Bot
@cardioonc_bot
unable to do my job since @TwitterDev just made getting #cardioonc information out to you $5,000. Cannot afford so bidding farewell.
ID: 1187846549751119874
25-10-2019 21:41:08
35,35K Tweet
779 Followers
1 Following

.Mamas A. Mamas thank you for providing one of the most timely and important lectures on treating cardiovascular disease in the oncology patient today. One of the best lectures I’ve ever had the privilege of attending. #CardioOnc American College of Cardiology

"Kickstart #GCOS23 Day 1 with a Research Symposium and keynote by Valentin Fuster! Bonnie Ky & Carlo Tocchetti spearhead the 1st session. Fadi N Salloum navigates cardio toxicities prevention, then Dr. Kitsis discusses new mitochondrial therapies. Brace yourselves!"International Cardio-Oncology Society






A #JACCCardioOnc study found that anticoagulants do not decrease the risk of ATEs for ambulatory cancer patients on systemic therapy. Read more in CancerTherapyAdvisor: bit.ly/3JUXqYO #cvCoag


1/🔥 off the press. Had the pleasure of writing an editorial on an interesting paper characterizing PH phenotypes in patients with #mpnsm in ATS Blue Journal with Gaby Hobbs and Brenda García 🫁. Great 🫀🫁🩸 collaboration. #cardioonc #cardioheme. A short🧵 atsjournals.org/doi/abs/10.116…

Are we close to unravel underlying mechanisms and targets for cardio-oncology patients? How do we need to use biomarkers in this field? New insights in JACC: CO jacc.org/doi/10.1016/j.… JACC Journals International Cardio-Oncology Society Rudolf de Boer Javid Moslehi Joseph Pierre Aboumsallèm Erasmus MC

Hot off the press! Biomarkers are crucial in the diagnosis of ICI myotoxicity. This review goes through the most recent data and provides guidance on their use. #cardioonc U-M Health Frankel CVC DrJE-Salem Alexi Vasbinder, PhD, RN @anisi_a_ismail doi.org/10.1007/s11886…

Another brick in the wall on the understanding of ICI mediated cardiovascular toxicities Javid Moslehi Wouter Meijers #cardiooncology #immunotherapy #vasculitis. CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis | Circulation Research ahajournals.org/doi/10.1161/CI…

4/ CS can be classified into 2 types in the new cardio-oncology syndrome classification (International Cardio-Oncology Society) Type 1 CS caused by cancer itself or indirectly through increased coronary risk, thromboembolic events, tamponade, or paraneoplastic syndrome. …rdiooncologyjournal.biomedcentral.com/articles/10.11…

"We're back on track with #GCOS23! Day 2 unfolds with two separate, yet equally insightful sessions. We kick-start with EHJ Editor-in-Chief, followed up by JACC CardioOncology addressing top cardio-oncology articles that will change practice & a roadmap for the cardio-oncology field!!"


Artificial intelligence and CardioOncology 👇 International Cardio-Oncology Society Puls Medycyny Monika Majewska Kasia Matusewicz

